Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2

Chiranjeevi Gadiparthi; Abhilash Perisetti; Hari Sayana; Benjamin Tharian; Sumant Inamdar; Andrew Korman

doi:10.14309/ajg.0000000000000719

Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2

Chiranjeevi Gadiparthi, Abhilash Perisetti, Hari Sayana, Benjamin Tharian, Sumant Inamdar, Andrew Korman

Division of Gastroenterology

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.

Original language	English (US)
Pages (from-to)	1283-1285
Number of pages	3
Journal	American Journal of Gastroenterology
Volume	115
Issue number	8
DOIs	https://doi.org/10.14309/ajg.0000000000000719
State	Published - Aug 1 2020

ASJC Scopus subject areas

Gastroenterology
Hepatology

Access to Document

10.14309/ajg.0000000000000719

Cite this

@article{31e81272339a4d88ae9346c0cc0eefbc,

title = "Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2",

abstract = "Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.",

author = "Chiranjeevi Gadiparthi and Abhilash Perisetti and Hari Sayana and Benjamin Tharian and Sumant Inamdar and Andrew Korman",

year = "2020",

month = aug,

day = "1",

doi = "10.14309/ajg.0000000000000719",

language = "English (US)",

volume = "115",

pages = "1283--1285",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "8",

}

TY - JOUR

T1 - Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2

AU - Gadiparthi, Chiranjeevi

AU - Perisetti, Abhilash

AU - Sayana, Hari

AU - Tharian, Benjamin

AU - Inamdar, Sumant

AU - Korman, Andrew

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.

AB - Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.

UR - http://www.scopus.com/inward/record.url?scp=85089204376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089204376&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000000719

DO - 10.14309/ajg.0000000000000719

M3 - Article

C2 - 32516204

AN - SCOPUS:85089204376

SN - 0002-9270

VL - 115

SP - 1283

EP - 1285

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 8

ER -

Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this